Valsartan Tablet, Film Coated
Product Images NDC 51660-142
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 51660-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ohm Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel-40 mg (Valsartan 2)
This appears to be a table of subgroups analyzed in a study called VALIANT, which evaluated effects on mortality. The subgroups include the patient demographic information such as age, gender, ethnicity, and use of medication (beta-blockers). The table includes columns that indicate the percentage of patients in each subgroup and whether they were treated with Valsartan or Captopril. The table also includes information on the direction of the effect (favoring Valsartan or Captopril) for each subgroup.*
Principal Display Panel-80 mg (Valsartan 3)
Principal Display Panel-160 mg (Valsartan 4)
Principal Display Panel-320 mg (Valsartan 5)
Valsartan 6
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.